Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
Journal Article (Journal Article)
Pulmonary arterial hypertension (PAH) is often difficult to diagnose and challenging to treat. Untreated, it is characterized by a progressive increase in pulmonary vascular resistance leading to right ventricular failure and death. The past decade has seen remarkable improvements in therapy, driven largely by the conduct of randomized controlled trials. Still, the selection of most appropriate therapy is complex, and requires familiarity with the disease process, evidence from treatment trials, complicated drug delivery systems, dosing regimens, side effects, and complications. This chapter will provide evidence-based treatment recommendations for physicians involved in the care of these complex patients. Due to the complexity of the diagnostic evaluation required, and the treatment options available, it is strongly recommended that consideration be given to referral of patients with PAH to a specialized center.
Full Text
Duke Authors
Cited Authors
- Badesch, DB; Abman, SH; Ahearn, GS; Barst, RJ; McCrory, DC; Simonneau, G; McLaughlin, VV; American College of Chest Physicians,
Published Date
- July 1, 2004
Published In
Volume / Issue
- 126 / 1 Suppl
Start / End Page
- 35S - 62S
PubMed ID
- 15249494
International Standard Serial Number (ISSN)
- 0012-3692
Digital Object Identifier (DOI)
- 10.1378/chest.126.1_suppl.35S
Language
- eng
Conference Location
- United States